PWP1 (Peptidylprolyl Isomerase Domain and WD Repeat Containing 1) is a critical component in cellular mechanisms, particularly noted for its involvement in ribosome biogenesis and the regulation of chromatin structure. The protein functions by leveraging its peptidyl-prolyl cis-trans isomerase (PPIase) activity to assist in proper protein folding and facilitating the assembly of protein complexes, a crucial step for the synthesis and functional integrity of ribosomes. Additionally, the presence of WD repeats within PWP1 underscores its role in mediating protein-protein interactions, thus contributing to its diverse functionality, including maintenance of chromatin structure and involvement in cell cycle regulation. These processes are vital for cellular growth, proliferation, and the maintenance of genomic stability, positioning PWP1 as a key player in the maintenance of cellular homeostasis.
The inhibition of PWP1 could therefore have profound implications on cellular physiology, affecting both ribosome biogenesis and chromatin dynamics. Mechanisms leading to the inhibition of PWP1 may include the alteration of its PPIase activity through direct binding of inhibitors, which could interfere with its ability to catalyze protein folding. Additionally, modifications to the WD repeats might disrupt PWP1's capacity to form complexes with other proteins, hindering its role in the assembly of ribosomal subunits and the organization of chromatin. Post-translational modifications such as phosphorylation or ubiquitination might also contribute to the regulation of PWP1 by affecting its stability, localization, or interaction with other cellular components. These inhibitory processes can lead to a cascade of cellular dysfunctions, including impaired ribosome assembly, disrupted gene expression due to alterations in chromatin structure, and compromised cell cycle progression. Understanding the intricacies of PWP1 inhibition is thus crucial for elucidating its multifaceted roles in cellular processes and the consequences of its dysregulation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Binds to the cyclophilin family of peptidylprolyl isomerases, inhibiting their isomerase activity and protein folding. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Binds to FKBP12, another peptidylprolyl isomerase, disabling its protein folding activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Forms a complex with FKBP12 and can inhibit mTOR, a kinase involved in signal transduction pathways. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Binds to Hsp90, potentially disrupting protein folding and signal transduction processes PWP1 may be involved in. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Disrupts protein-protein interactions, which could affect WD repeat-containing proteins like PWP1. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Modulates protein kinases and phosphatases, potentially altering signaling pathways involving PWP1. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Inhibits calmodulin, affecting calcium signaling pathways that could indirectly influence PWP1 activity. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
Disrupts certain chloride channels, which can alter cell signaling and potentially influence PWP1-related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Another MEK inhibitor, altering MAPK/ERK signaling that could be connected to PWP1 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, which may play a role in signaling pathways associated with PWP1. | ||||||